Diagnostic and Therapeutic Conundrums in Systemic Sclerosis Interstitial Lung Disease
Systemic Sclerosis (SSc) is a disease characterized by a complex interplay between inflammation, vascular and fibrotic mechanisms with no single unifying pathogenic mechanism. The clinical phenotype is a result of vascular endothelial dysfunction, ongoing inflammation and autoimmunity or fibroblasti...
Saved in:
Main Authors: | Ramaswamy Subramanian (Author), Vinod Ravindran (Author) |
---|---|
Format: | Book |
Published: |
Dr. Annil Mahajan,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
by: Elisabetta Zanatta, et al.
Published: (2022) -
Ultrasound lung comets: new echographic sign of lung interstitial fibrosis in systemic sclerosis
by: C. Giacomelli, et al.
Published: (2011) -
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review
by: Martina Orlandi, et al.
Published: (2022) -
Management of Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: A Focus on the Role of the Pharmacist
by: Farrell J, et al.
Published: (2023) -
The relationship between serum level of matrix metalloproteinase-7 and interstitial lung disease in patients with systemic sclerosis
by: Mervat M Abo Gabal, et al.
Published: (2019)